Amazon.com Inc. (NYSE: AMZN), JPMorgan Chase & Co. (NYSE: JPM) and Berkshire Hathaway Inc. (NYSE: BRK-B) are now making their combined health care plan a reality with the appointment of a new chief executive officer. The trio originally set out to subvert the current health insurance system and create a company of their own that could better handle the needs of their employees, and it seems that this plan is now coming to fruition.
According to a press release, Ariadne Labs founder and Executive Director Dr. Atul Gawande has been named the CEO of the new Amazon, JPMorgan, Berkshire Hathaway nonprofit health care organization. The appointment was announced Wednesday jointly by Amazon CEO Jeff Bezos, Berkshire Hathaway CEO Warren Buffett and JPMorgan CEO Jamie Dimon.
Gawande will assume this role effective July 9, and the new company will be headquartered in Boston and will operate as an independent entity that is free from profit-making incentives and constraints.
Gawande is a globally-renowned surgeon, writer and public health innovator. He practices general and endocrine surgery at Brigham and Women’s Hospital and is a professor at the Harvard T.H. Chan School of Public Health and Harvard Medical School. He is founding executive director of the health systems innovation center, Ariadne Labs.
I am thrilled about this opportunity as it aligns perfectly with my personal mission. I have devoted my public health career to working with colleagues to build scalable solutions for better health care delivery in the U.S. and across the world. Now, I have the support of these remarkable organizations to pursue this mission for their employees and families in ways that incubate better models of care for all. And I will be able to do so while maintaining my own voice and continuing to enable Ariadne Labs’ powerful and complementary work.